Tag Archives: Hepatitis C Drugs Market 2022

Hepatitis C Drugs market worldwide research, trends and development of 2022

The Analysis presents the study of Worldwide Hepatitis C Drugs facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.

Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepatitis C is caused by hepatitis C virus and affects between 130–150 million people globally every year of which approximately 700 000 people die from hepatitis C-related liver diseases. What is of greater concern is the fact that 15 to 20% of chronically infected patients develop liver cirrhosis or liver cancer